{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:57:06Z","timestamp":1785243426016,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["#73305095007"],"award-info":[{"award-number":["#73305095007"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Holland","award":["#LSHM20106"],"award-info":[{"award-number":["#LSHM20106"]}]},{"name":"HorstingStuit Foundation, the Hans und Ilse Breuer Foundation and Stichting VUmc Fund"},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["101034371"],"award-info":[{"award-number":["101034371"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The rs72824905 single-nucleotide polymorphism in the\n                      <jats:italic>PLCG2<\/jats:italic>\n                      gene, encoding the p.P522R residue change in Phospholipase C gamma 2 (PLC\u03b32), associates with protection against several dementia subtypes and with increased likelihood of longevity. Cell lines and animal models indicated that p.P522R is a functional hypermorph. We aimed to confirm this in human circulating peripheral immune cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared effects of p.P522R on immune system function between carriers and non-carriers (aged 59-103y), using in-depth immunophenotyping, functional B-cell and myeloid cell assays, and in vivo SARS-CoV-2 vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In line with expectations, p.P522R impacts immune cell function only slightly, but it does so across a wide array of immune cell types. Upon B-cell stimulation, we observed increased PLC\u03b32 phosphorylation and calcium release, suggesting increased B-cell sensitivity upon antigen recognition. Further, p.P522R-carriers had higher numbers of CD20++CD21-CD24+ naive B cells and IgG1+ memory B cells. In myeloid cells, normalized ROS production was higher upon PLC\u03b32-dependent stimulation. On classical monocytes, CD33 levels were elevated. Furthermore, carriers expressed lower levels of allergy-related Fc\u03b5RI on several immune cell subsets. Nevertheless, carriers and non-carriers had similar serological responses to SARS-CoV-2 vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The immune system from p.P522R-carriers is slightly more responsive to stimulation than in non-carriers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-023-00604-9","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T11:58:23Z","timestamp":1681991903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Carriers of the p.P522R variant in PLC\u03b32 have a slightly more responsive immune system"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-805X","authenticated-orcid":false,"given":"Annieck M.","family":"Diks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Teodosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Mooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick J.","family":"Groenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta A. E.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge F.","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Vloemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Horsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena A.","family":"Berkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henne","family":"Holstege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"1","key":"604_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/09513590.2013.852531","volume":"30","author":"C Castelo-Branco","year":"2014","unstructured":"Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol. 2014;30(1):16\u201322.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"604_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonaf\u00e8 M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908(1):244\u201354.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"604_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.it.2009.04.005","volume":"30","author":"MP Cancro","year":"2009","unstructured":"Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, et al. B cells and aging: molecules and mechanisms. Trends Immunol. 2009;30(7):313\u20138.","journal-title":"Trends Immunol"},{"key":"604_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-cellbio-011620-034148","volume":"36","author":"D Frasca","year":"2020","unstructured":"Frasca D, Diaz A, Romero M, Garcia D, Blomberg BB. B cell immunosenescence. Ann Rev Cell Dev Biol. 2020;36:551\u201374.","journal-title":"Ann Rev Cell Dev Biol"},{"issue":"5","key":"604_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1089\/rej.2008.0750","volume":"11","author":"CF Fortin","year":"2008","unstructured":"Fortin CF, McDonald PP, Lesur O, F\u00fcl\u00f6p T Jr. Aging and neutrophils: there is still much to do. Rejuvenation Res. 2008;11(5):873\u201382.","journal-title":"Rejuvenation Res"},{"issue":"2","key":"604_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4049\/jimmunol.154.2.832","volume":"154","author":"JA McLachlan","year":"1995","unstructured":"McLachlan JA, Serkin CD, Morrey KM, Bakouche O. Antitumoral properties of aged human monocytes. J Immunol. 1995;154(2):832\u201343.","journal-title":"J Immunol"},{"issue":"5","key":"604_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1474-9726.2012.00851.x","volume":"11","author":"AC Hearps","year":"2012","unstructured":"Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, Landay AL, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell. 2012;11(5):867\u201375.","journal-title":"Aging Cell"},{"key":"604_CR8","doi-asserted-by":"crossref","unstructured":"Dong C, Yr M, Zhao R, Yang M, Ay G, Xue Z, et al. Single-cell transcriptomics reveals longevity immune remodeling features shared by centenarians and their offspring. Adv Sci. 2022;9(36):2204849.","DOI":"10.1002\/advs.202204849"},{"issue":"9","key":"604_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017;49(9):1373\u201384.","journal-title":"Nat Genet"},{"key":"604_CR10","doi-asserted-by":"crossref","unstructured":"van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer\u2019s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 2019;138(2):237\u201350.","DOI":"10.1007\/s00401-019-02026-8"},{"key":"604_CR11","doi-asserted-by":"crossref","unstructured":"Wagner K-H, Cameron-Smith D, Wessner B, Franzke BJN. Biomarkers of aging: from function to molecular biology. Nutrients. 2016;8(6):338.","DOI":"10.3390\/nu8060338"},{"issue":"10","key":"604_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0898-6568(01)00191-7","volume":"13","author":"JI Wilde","year":"2001","unstructured":"Wilde JI, Watson SP. Regulation of phospholipase C \u03b3 isoforms in haematopoietic cells: why one, not the other? Cell Signal. 2001;13(10):691\u2013701.","journal-title":"Cell Signal"},{"issue":"1","key":"604_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1074-7613(00)00005-4","volume":"13","author":"D Wang","year":"2000","unstructured":"Wang D, Feng J, Wen R, Marine J-C, Sangster MY, Parganas E, et al. Phospholipase C\u03b32 is essential in the functions of B cell and several fc receptors. Immunity. 2000;13(1):25\u201335.","journal-title":"Immunity."},{"key":"604_CR14","doi-asserted-by":"crossref","unstructured":"Takalo M, Wittrahm R, Wefers B, Parhizkar S, Jokivarsi K, Kuulasmaa T, et al. The Alzheimer\u2019s disease-associated protective Plc\u03b32-P522R variant promotes immune functions. Molecular Neurodegeneration. 2020;15(1):1\u201314.","DOI":"10.1186\/s13024-020-00402-7"},{"key":"604_CR15","doi-asserted-by":"crossref","unstructured":"Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, van Lengerich B, et al. Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23(8):927\u201338.","DOI":"10.1038\/s41593-020-0650-6"},{"issue":"6","key":"604_CR16","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1074\/jbc.C111.328559","volume":"287","author":"C-Y Chiang","year":"2012","unstructured":"Chiang C-Y, Veckman V, Limmer K, David M. Phospholipase C\u03b3-2 and intracellular calcium are required for lipopolysaccharide-induced toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem. 2012;287(6):3704\u20139.","journal-title":"J Biol Chem"},{"key":"604_CR17","doi-asserted-by":"crossref","unstructured":"Strickland SL, Morel H, Prusinski C, Allen M, Patel TA, Carrasquillo MM, et al. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy. Acta Neuopathol Commun. 2020;8(1):1\u201312.","DOI":"10.1186\/s40478-020-01050-0"},{"key":"604_CR18","doi-asserted-by":"crossref","unstructured":"Chen F, Zhang Y, Wang L, Wang T, Han Z, Zhang H, Gao S, Hu Y, Liu GJJoAsD. PLCG2 rs72824905 variant reduces the risk of alzheimer\u2019s disease and multiple sclerosis. J Alzheimer's Dis. 2021;80(1):71\u20137.","DOI":"10.3233\/JAD-201140"},{"issue":"6","key":"604_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam L, Chouraki V, Pr\u00f3chnicki T, van der Lee SJ, Madrid-Marquez L, Wagner-Thelen H, et al. PLCG2 protective variant p. P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020;139(6):1025\u201344.","journal-title":"Acta Neuropathol"},{"key":"604_CR20","doi-asserted-by":"crossref","unstructured":"Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimer's Res Ther. 2019;11(1):16.","DOI":"10.1186\/s13195-019-0469-0"},{"key":"604_CR21","doi-asserted-by":"crossref","unstructured":"Maguire E, Menzies GE, Phillips T, Sasner M, Williams HM, Czubala MA, et al. PIP2 depletion and altered endocytosis caused by expression of Alzheimer's disease-protective variant PLC\u03b32 R522. EMBO J. 2021;40(17):e105603.","DOI":"10.15252\/embj.2020105603"},{"key":"604_CR22","doi-asserted-by":"crossref","unstructured":"Holstege H, Beker N, Dijkstra T, Pieterse K, Wemmenhove E, Schouten K, et al. The 100-plus study of cognitively healthy centenarians: rationale, design and cohort description. Eur J Epidemiol. 2018;33(12):1229\u201349.","DOI":"10.1007\/s10654-018-0451-3"},{"issue":"2","key":"604_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41431-018-0273-5","volume":"27","author":"N Tesi","year":"2019","unstructured":"Tesi N, van der Lee SJ, Hulsman M, Jansen IE, Stringa N, van Schoor N, et al. Centenarian controls increase variant effect sizes by an average twofold in an extreme case\u2013extreme control analysis of Alzheimer\u2019s disease. Eur J Hum Genet. 2019;27(2):244\u201353.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"604_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cyto.a.22581","volume":"87","author":"T Kalina","year":"2015","unstructured":"Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira CE, Velden VH, Novakova M, et al. Quality assessment program for EuroFlow protocols: summary results of four-year (2010\u20132013) quality assurance rounds. Cytometry Part A. 2015;87(2):145\u201356.","journal-title":"Cytometry Part A"},{"issue":"9","key":"604_CR25","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","volume":"26","author":"T Kalina","year":"2012","unstructured":"Kalina T, Flores-Montero J, Van Der Velden V, Martin-Ayuso M, B\u00f6ttcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012;26(9):1986\u20132010.","journal-title":"Leukemia."},{"key":"604_CR26","doi-asserted-by":"crossref","unstructured":"van der Pan K, de Bruin-Versteeg S, Damasceno D, Hern\u00e1ndez-Delgado A, van der Sluijs-Gelling AJ, van den Bossche WB, et al. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood. Front Immunol. 2022;13:935879.","DOI":"10.3389\/fimmu.2022.935879"},{"key":"604_CR27","unstructured":"van Dongen JJM, Orfao de Matos Correia E Vale JA, Goncalves Grunho Teodosio CI, Perez Y Andres M, Almeida Parra JM, Van den Bossche WBL, et al. P119646NL00. PCT\/NL2020\/050688. Means and methods for multiparameter cytometry-based leukocyte subsetting. 2019."},{"key":"604_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fimmu.2020.00166","volume":"11","author":"V Botafogo","year":"2020","unstructured":"Botafogo V, P\u00e9rez-Andres M, Jara-Acevedo M, B\u00e1rcena P, Grigore G, Hern\u00e1ndez-Delgado A, et al. Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-color EuroFlow immune monitoring tube. Front Immunol. 2020;11:166.","journal-title":"Front Immunol"},{"issue":"6","key":"604_CR29","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","volume":"141","author":"E Blanco","year":"2018","unstructured":"Blanco E, P\u00e9rez-Andr\u00e9s M, Arriba-M\u00e9ndez S, Contreras-Sanfeliciano T, Criado I, Pelak O, et al. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J Allergy Clin Immunol. 2018;141(6):2208\u201319 e16.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"604_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/vaccines10020136","volume":"10","author":"AM Diks","year":"2022","unstructured":"Diks AM, Versteegen P, Teodosio C, Groenland RJ, de Mooij B, Buisman A-M, et al. Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination. Vaccines (Basel). 2022;10(2):136.","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"604_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"W1","key":"604_CR32","doi-asserted-by":"publisher","first-page":"W603","DOI":"10.1093\/nar\/gkab410","volume":"49","author":"N Tesi","year":"2021","unstructured":"Tesi N, Van Der Lee S, Hulsman M, Holstege H, Reinders MJ. snpXplorer: a web application to explore human SNP-associations and annotate SNP-sets. Nucleic Acids Res. 2021;49(W1):W603\u2013W12.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"604_CR33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, et al. Multifunctional TH 1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13(7):843\u201350.","journal-title":"Nat Med"},{"key":"604_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2011.00012","volume":"2","author":"MC Van Zelm","year":"2011","unstructured":"Van Zelm MC, Van Der Burg M, Langerak AW, Van Dongen JJ. PID comes full circle: applications of V (D) J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol. 2011;2:12.","journal-title":"Front Immunol"},{"issue":"3","key":"604_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1084\/jem.20060964","volume":"204","author":"MC Van Zelm","year":"2007","unstructured":"Van Zelm MC, Szczepa\u0144ski T, Van Der Burg M, Van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204(3):645\u201355.","journal-title":"J Exp Med"},{"key":"604_CR36","doi-asserted-by":"crossref","unstructured":"Fr\u00f6berg J, Gillard J, Philipsen R, Lanke K, Rust J, van Tuijl D, et al. SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms. Nat Commun. 2021;12(1):5621.","DOI":"10.1038\/s41467-021-25949-x"},{"key":"604_CR37","doi-asserted-by":"crossref","unstructured":"Tsai AP, Dong C, Lin PB-C, Oblak AL, Di Prisco GV, Wang N, et al. Genetic Variants of Phospholipase C-\u03b3 2 Confer Altered Microglial Phenotypes and Differential Risk for Alzheimers Disease. bioRxiv. 2022.","DOI":"10.1101\/2022.12.08.519685"},{"issue":"48","key":"604_CR38","doi-asserted-by":"publisher","first-page":"eabd5575","DOI":"10.1126\/sciadv.abd5575","volume":"6","author":"T Phongpreecha","year":"2020","unstructured":"Phongpreecha T, Fernandez R, Mrdjen D, Culos A, Gajera CR, Wawro AM, et al. Single-cell peripheral immunoprofiling of Alzheimer\u2019s and Parkinson\u2019s diseases. Sci Adv. 2020;6(48):eabd5575.","journal-title":"Sci Adv"},{"issue":"1","key":"604_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1600-065X.2010.00939.x","volume":"237","author":"T Kurosaki","year":"2010","unstructured":"Kurosaki T, Aiba Y, Kometani K, Moriyama S, Takahashi Y. Unique properties of memory B cells of different isotypes. Immunol Rev. 2010;237(1):104\u201316.","journal-title":"Immunol Rev"},{"issue":"11","key":"604_CR40","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1128\/IAI.73.11.7465-7476.2005","volume":"73","author":"K Kolibab","year":"2005","unstructured":"Kolibab K, Smithson SL, Rabquer B, Khuder S, Westerink MJJI. Immunity Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire. Infect Immun. 2005;73(11):7465\u201376.","journal-title":"Infect Immun"},{"issue":"6","key":"604_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1474-9726.2011.00732.x","volume":"10","author":"A Ademokun","year":"2011","unstructured":"Ademokun A, Wu YC, Martin V, Mitra R, Sack U, Baxendale H, et al. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell. 2011;10(6):922\u201330.","journal-title":"Aging Cell"},{"issue":"8","key":"604_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41577-021-00652-6","volume":"22","author":"RW Jain","year":"2022","unstructured":"Jain RW, Yong VW. B cells in central nervous system disease: diversity, locations and pathophysiology. Nat Rev Immunol. 2022;22(8):513\u201324.","journal-title":"Nat Rev Immunol"},{"issue":"29","key":"604_CR43","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.0904866106","volume":"106","author":"M Britschgi","year":"2009","unstructured":"Britschgi M, Olin C, Johns H, Takeda-Uchimura Y, LeMieux M, Rufibach K, et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci. 2009;106(29):12145\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"604_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2006.01.072","volume":"410","author":"H Rosenmann","year":"2006","unstructured":"Rosenmann H, Meiner Z, Geylis V, Abramsky O, Steinitz M. Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects. Neurosci Lett. 2006;410(2):90\u20133.","journal-title":"Neurosci Lett"},{"issue":"7618","key":"604_CR45","first-page":"50","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nat Immunol. 2016;537(7618):50\u20136.","journal-title":"Nat Immunol"},{"issue":"1","key":"604_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00663-w","volume":"12","author":"M Tolar","year":"2020","unstructured":"Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M. Aducanumab, gantenerumab, BAN2401, and ALZ-801\u2014the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval. Alzheimer's Res Ther. 2020;12(1):1\u201310.","journal-title":"Alzheimer's Res Ther"},{"issue":"7","key":"604_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018;14(7):399\u2013415.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"604_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri2273","volume":"8","author":"HJ Gould","year":"2008","unstructured":"Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205\u201317.","journal-title":"Nat Rev Immunol"},{"key":"604_CR49","doi-asserted-by":"crossref","unstructured":"Spiegelberg H, Melewicz F, Ferreri N, editors. IgE Fc receptors on monocytes and allergy. Ann\u00a0Inst Pasteur Immunol.\u00a01986;137C(3):358\u201363.","DOI":"10.1016\/S0771-050X(86)80055-9"},{"key":"604_CR50","doi-asserted-by":"crossref","unstructured":"Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WEJN. Mast cell lines produce lymphokines in response to cross-linkage of Fc\u03b5RI or to calcium ionophores. Nature. 1989;339(6219):64\u20137.","DOI":"10.1038\/339064a0"},{"key":"604_CR51","doi-asserted-by":"crossref","unstructured":"Jiang T, Yu J-T, Hu N, Tan M-S, Zhu X-C, Tan LJ. CD33 in Alzheimer's disease. Mol Neurobiol. 2014;49(1):529\u201335.","DOI":"10.1007\/s12035-013-8536-1"},{"issue":"7","key":"604_CR52","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, et al. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16(7):848\u201350.","journal-title":"Nat Neurosci"},{"issue":"4","key":"604_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631\u201343.","journal-title":"Neuron."},{"issue":"11","key":"604_CR54","doi-asserted-by":"publisher","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS One. 2012;7(11):e50976.","journal-title":"PLoS One"},{"issue":"5","key":"604_CR55","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BN, Buros J, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011;43(5):436\u201341.","journal-title":"Nat Genet"},{"issue":"2","key":"604_CR56","first-page":"425","volume":"61","author":"T F\u00fcl\u00f6p Jr","year":"1985","unstructured":"F\u00fcl\u00f6p T Jr, Foris G, Worum I, Le\u00f6vey A. Age-dependent alterations of fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes. Clin Exp Immunol. 1985;61(2):425.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"604_CR57","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1189\/jlb.70.6.881","volume":"70","author":"S Butcher","year":"2001","unstructured":"Butcher S, Chahal H, Nayak L, Sinclair A, Henriquez N, Sapey E, et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol. 2001;70(6):881\u20136.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"604_CR58","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jnr.24419","volume":"98","author":"E Gaband\u00e9-Rodr\u00edguez","year":"2020","unstructured":"Gaband\u00e9-Rodr\u00edguez E, Keane L, Capasso MJ. Microglial phagocytosis in aging and Alzheimer's disease. J Neurosci Res. 2020;98(2):284\u201398.","journal-title":"J Neurosci Res"},{"issue":"5","key":"604_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neurobiolaging.2003.12.026","volume":"25","author":"MR D\u2019Andrea","year":"2004","unstructured":"D\u2019Andrea MR, Cole GM, Ard MD. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging. 2004;25(5):675\u201383.","journal-title":"Neurobiol Aging"},{"key":"604_CR60","doi-asserted-by":"crossref","unstructured":"Claes C, England WE, Danhash EP, Kiani Shabestari S, Jairaman A, Chadarevian JP, et al. The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model. Alzheimers Dement. 2022;18(10):1765\u201378","DOI":"10.1002\/alz.12577"},{"key":"604_CR61","doi-asserted-by":"crossref","unstructured":"Garner C, Tatu T, Reittie J, Littlewood T, Darley J, Cervino S, et al. The journal of the American Society of Hematology. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood. 2000;95(1):342\u20136.","DOI":"10.1182\/blood.V95.1.342.001k33_342_346"},{"issue":"7","key":"604_CR62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/sj.gene.6363702","volume":"1","author":"M Hall","year":"2000","unstructured":"Hall M, Ahmadi K, Norman P, Snieder H, MacGregor A, Vaughan R, et al. Genetic influence on peripheral blood T lymphocyte levels. Immunity. 2000;1(7):423\u20137.","journal-title":"Immunity"},{"key":"604_CR63","unstructured":"Guen YL, Luo G, Ambati A, Damotte V, Jansen I, Yu E, et al. Protective association of HLA-DRB1*04 subtypes in neurodegenerative diseases implicates acetylated Tau PHF6 sequences. Alzheimers Dement. 2022;18(Suppl. 3):e060159"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00604-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00604-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00604-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:09:11Z","timestamp":1681996151000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00604-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00604-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1929710\/v1","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, we selected 36 individuals from the 100 plus study cohort, as previously described by Holstege et al (METC number: 2016.440, approved by the Medical Ethics Committee of the VU University Medical Center, Amsterdam, the Netherlands). Informed consent was obtained from each study participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AMD, CT, JJMvD and MAB report inventorship of the patent \u201cMeans and methods for multiparameter cytometry-based leukocyte subsetting\u201d (NL2844751, PCT\/NL2020\/050688, filing date 5 November 2019), owned by the EuroFlow Consortium. In addition, JJMvD reports to be chairman of the EuroFlow scientific foundation, which receives royalties from licensed patents, which are collectively owned by the participants of the EuroFlow Foundation. These royalties are exclusively used for continuation of the EuroFlow collaboration and sustainability of the EuroFlow consortium. JJMvD reports an Educational Services Agreement from BD Biosciences (San Jos\u00e9, CA) and a Scientific Advisor Agreement with Cytognos; all related fees and honoraria are for the Immunology department at Leiden University Medical Center. All other authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}